As of 2026-03-30, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 23.7x | 19.6x |
| Forward P/E multiples | 14.4x - 20.4x | 17.8x |
| Fair Price | (12.00) - (14.92) | (13.64) |
| Upside | -21150.5% - -26281.5% | -24030.2% |
| Date | EV/EBITDA |